AGL Investor Alert: Shareholders of agilon health, inc. (NYSE: AGL) With Losses Over US$100,000 — Here’s What You Should Know

A leading investor‑rights firm, The Rosen Law Firm, has announced it is investigating potential securities‑law claims on behalf of shareholders of agilon health, inc. (NYSE: AGL). The probe follows allegations that agilon provided materially misleading business information to the investing public. Investors who purchased AGL securities and suffered losses exceeding US$100,000 may be eligible for compensation — under a contingency‑fee arrangement, meaning no upfront fees or costs. The legal action centers on a troubled disclosure from agilon: On August 4, 2025, the company reported its second‑quarter results and warned that industry headwinds were “more acute than previously expected.” Alongside this, agilon withdrew its full‑year 2025 financial guidance. The market reacted harshly — on August 5, 2025, AGL’s share price plunged about 51.5%. For shareholders interested in joining the proposed class action, The Rosen Law Firm is accepting submissions through a form on its website or via a toll‑free phone call (866‑767‑3653), or by emailing . The firm highlights its history of successful securities class‑action litigation: it has recovered hundreds of millions for investors and previously earned the top ranking from ISS Securities Class Action Services for number of settlements. Investors considering action are encouraged to act quickly and consult qualified counsel. #agilonHealth #AGL #InvestorRights #ClassAction #SlimScan #GrowthStocks #CANSLIM